100% of trades were $15,000 or less
Those 11 trades carry about 100% of the disclosed dollars, by the midpoints of the ranges.
Andrew Garbarino
Representative
NY-2
Republican
2025 disclosure
Andrew Garbarino (NY-2) disclosed a net worth range between -$510K and $53K in their 2025 annual filing.
Compare this disclosure with the House of Representatives net worth rankings .
Trading
Disclosed stock trades
11
Since Q3 '25
Purchases
45%
Share of disclosed trades
Avg. disclosure lag
23.3 days
Median 31 days
Filed past 45-day deadline
0%
STOCK Act deadline
100% of trades were disclosed within 45 days
The median trade was disclosed 31 days after it was made, and 0 of 11 trades took longer than the STOCK Act deadline.
Purchases and sales by quarter
Trades by quarter of trade
Purchases
Sales
Quarter in progress
Source: periodic transaction reports, machine-readable only.
ORMP is the most traded stock
Trades per stock
Purchases
Sales
Net worth
Estimated from the ranges in the member's annual financial disclosures: the band runs from the sum of disclosed asset minimums less liability maximums up to the sum of asset maximums less liability minimums. Only electronically filed reports are read — a missing year means no electronic filing, not zero net worth.
Latest net worth (band)
-$510K – $53K
Rank by disclosed net worth
Reporting year
2025
Disclosed assets
16
Disclosed liabilities
2
Disclosed net worth band, 2021 to 2025
Band from annual financial disclosures, by reporting year
Band maximum
Band minimum
Source: annual financial disclosure reports, electronically filed only.
2021
2022
2023
2024
2025
| Year | Filed | Net worth band |
|---|---|---|
| 2025 | 2026-08-06 | -$510K – $53K |
| 2024 | 2025-08-13 | -$495K – $103K |
| 2023 | 2024-08-13 | -$494K – $118K |
| 2022 | 2023-08-13 | -$472K – $149K |
| 2021 | 2022-08-10 | -$475K – $104K |
Recent stock trades
| Date | Stock | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|
| 2025-08-21 | GAP ST · Gap, Inc. (GAP) | Sell | — Stock Account | $1K - $15K | 2025-08-21 | 0d |
| 2022-01-14 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) | Sell | — Stock Account | $1K - $15K | 2022-01-14 | 0d |
| 2022-01-14 | TELL ST · Tellurian Inc. (TELL) | Buy | — Stock Account | $1K - $15K | 2022-01-14 | 0d |
| 2021-10-01 | GPS ST · Gap, Inc. (GPS) | Buy | — Stock Account | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | OSW ST · OneSpaWorld Holdings Limited - Common Shares (OSW) | Sell | — Stock Account | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) | Sell | — Stock Account | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | TELL ST · Tellurian Inc. (TELL) | Buy | — Stock Account | $1K - $15K | 2021-11-03 | 33d |
| 2021-04-23 | BAC ST · bank of America Corporation (bAC) | Sell | — Stock Account | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | GSS ST · Golden Star Resources, Ltd (GSS) | Sell | — Stock Account | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | OSW ST · OneSpaWorld Holdings Limited - Common Shares (OSW) | Buy | — Stock Account | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) | Buy | — Stock Account | $1K - $15K | 2021-05-24 | 31d |
Estimated portfolio performance
Price return of the portfolio reconstructed from this member's disclosed trades over each trailing window, versus the S&P 500 (SPY), as of 2026-11-06. Trade sizes are disclosed only as ranges, so every figure is an estimate. Returns use comparable raw closes and exclude dividends; a window crossing a captured split is left unavailable instead of mixing price bases.
| Window | Portfolio | SPY | vs SPY |
|---|---|---|---|
| 1 week | +3.0% | -2.7% | +5.7% |
| 1 month | +33.7% | -5.6% | +39.3% |
| 1 quarter | +17.3% | -4.3% | +21.7% |
| Year to date | +50.1% | +7.8% | +42.3% |
Reconstructed holdings
The portfolio reconstructed from this member's disclosed Purchase and Sale trades: net shares valued at the latest close (2026-11-06). Sizes come from disclosed amount ranges, so share counts, values, and weights are all estimates.
| Stock | Est. shares | Est. value | Weight |
|---|---|---|---|
| OSW | 8 | $257 | 100.0% |
Assets and liabilities
Disclosed assets
The assets Andrew Garbarino itemised in their 2025 annual report, largest bracket first. Descriptions are the filer's own wording, and each value is the bracket they checked on the form — never a reported amount.
Disclosed lines
16
Total disclosed (band)
$90K – $353K
| Description | Type | Income | Value |
|---|---|---|---|
| MetLife Whole Life Insurance | WU |
Tax-Deferred
|
$50K - $100K |
| Andrew Roth IRA ⇒ American Beacon ARK Transformational Innovation Fund - C Class (ADNCX) | MF |
Tax-Deferred
|
$15K - $50K |
| PennMutual Whole Life | WU |
Tax-Deferred
|
$15K - $50K |
| Andrew Roth IRA ⇒ Roper Technologies, Inc. (ROP) | ST |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ The Growth Fund of America Class A Shares (AGTHX) | MF |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ Virtus KAR Mid-Cap Core Fund C (VMCCX) | MF |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ Zoetis Inc. Class A Common Stock (ZTS) | ST |
Tax-Deferred
|
$1K - $15K |
| Bristol-Myers Squibb Company Common Stock (BMY) | ST |
$1 - $200
Dividends
|
$1K - $15K |
| Capital One Bank Account | BA |
$201 - $1K
Interest
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2040 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2045 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2050 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| TD Bank Account | BA |
$201 - $1K
Interest
|
$1K - $15K |
| Andrew Roth IRA ⇒ AT&T Inc. (T) | ST |
Tax-Deferred
|
$1 - $1K |
| Andrew Roth IRA ⇒ Intel Corporation - Common Stock (INTC) | ST |
Tax-Deferred
|
$1 - $1K |
| Andrew Roth IRA ⇒ MDU Resources Group, Inc. Common Stock (MDU) | ST |
Tax-Deferred
|
$1 - $1K |
Disclosed liabilities
The liabilities itemised in the 2025 annual report, largest bracket first. These are the amounts subtracted when the net worth band above is rolled up.
Disclosed lines
2
Total disclosed (band)
$300K – $600K
| Description | Amount owed |
|---|---|
| Home Mortgage Refinance (Ridgewood Savings Bank) | $250K - $500K |
| Law School Student Loans (Aidvantage) | $50K - $100K |